Show simple item record

dc.date.accessioned2020
dc.date.available2020
dc.date.issued2020
dc.identifier.govdocPAHO/IMS/EIH/COVID-19/20-0018
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52672
dc.description.abstractMore than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we have examined 40 therapeutic options. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectPandemicsen_US
dc.subjectBetacoronavirusen_US
dc.subjectInfection Controlen_US
dc.subjectResearchen_US
dc.subjectInfectious Disease Medicineen_US
dc.subjectEvidence-Based Emergency Medicineen_US
dc.subjectTherapeutic Approachesen_US
dc.titleOngoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review, 8 September 2020en_US
dc.typeProcedures, manuals, guidelinesen_US
dc.typeTechnical reportsen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.contributor.departmentEvidence and Intelligence for Action in Health (EIH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO